16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Participants With End Stage Renal Disease (ESRD) Requiring Chronic Hemodialysis
Clinical trial NCT02260193 · COMPLETED
Trial details
- NCT number
- NCT02260193
- Sponsor
- Akebia Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-10
- Primary completion
- 2015-07-22
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.